Actively Recruiting
Transdiagnostic Online CBT Vs. Care As Usual for Primary Care Patients with Common Mental Disorders
Led by Karolinska Institutet · Updated on 2025-03-07
500
Participants Needed
1
Research Sites
203 weeks
Total Duration
On this page
Sponsors
K
Karolinska Institutet
Lead Sponsor
R
Region Stockholm
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this randomized controlled trial is to investigate if online transdiagnostic cognitive behavior therapy (CBT) can be effective in the treatment of common mental disorders in adult primary care patients. The main aim is to investigate: if online transdiagnostic CBT yields superior symptomatic improvement compared to care-as-usual when given in a primary care context to patients with a common mental disorder. Researchers will compare online transdiagnostic CBT to primary care as usual to see if psychiatric symptoms can be reduced. Participants will be randomized to online transdiagnostic CBT or primary care as usual. Participants in online transdiagnostic CBT will receive a cognitive behavioral treatment provided through a secure web platform in which psychoeducation, worksheets, and exercises are presented in online modules similar to chapters in a book. Participants will receive weekly written feedback on their work and progress by a therapist who gives gradual access to the treatment modules. The lion's share of the contact between the therapist and the patient thus takes place through messages (similar to email) in the online treatment platform. Participants randomized to care as usual will receive health care services as usual in primary care. As this comparator is intended to reflect real routine primary care, the interventions will not be controlled by the research project, but the investigators expect that participants will receive an active treatment.
CONDITIONS
Official Title
Transdiagnostic Online CBT Vs. Care As Usual for Primary Care Patients with Common Mental Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a diagnosed common mental disorder such as anxiety disorder, health anxiety, obsessive-compulsive disorder, depression, or stress-related disorder that needs treatment
- Be at least 18 years old
- Have regular access to a device with Internet connection
- Be able to read and write Swedish
- Have no severe psychiatric disorder requiring specialized care like psychosis, bipolar disorder, or anorexia nervosa
- If on monoamine agonist medication, have had a stable dose for the past month
- Not be currently receiving psychological treatment
- Provide written informed consent and complete baseline assessments
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Region Stockholm, Gustavsberg Primary Care Center
Gustavsberg, Stockholm County, Sweden, 134 40
Actively Recruiting
Research Team
M
Mari von Bahr Bentzer, MSc.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here